Exact Sciences Cologuard® test gets label expansion approval from FDA
Category: #health  By Paroma Bhattacharya  Date: 2019-09-24
  • share
  • Twitter
  • Facebook
  • LinkedIn

Exact Sciences Cologuard® test gets label expansion approval from FDA

Colorectal cancer cases are increasingly growing across the world, however it is one of those cancers which can be treated if diagnosed at early stages. Various pharmaceutical and medical firms in the world are continuously working to find effective treatments and spread more awareness on colorectal cancer. 

Exact Sciences Corp., an American molecular diagnostics firm with a primary focus on early colorectal cancer detection and prevention, reportedly announced that Cologuard, its noninvasive colorectal cancer screening test gained the approval for label expansion from the U.S. Food and Drug Administration (FDA).

The Cologuard can now be used by a younger demographic; people with ages ranging from 45 to 49 years.

Kevin Conroy, CEO of Exact Sciences stated that it is good news for Americans aged between 45 to 49 years since the approval has extended the screening age five years earlier than before. Conroy further added that approximately 20 million Americans that need to screen themselves for colon cancer. 

Colorectal cancer is said to be the most preventable but least prevented type of cancer. Colorectal cancer is second most deadly form of cancer in the United States. General screening is critical since colorectal cancer can be better treated if detected in early stages.

Backed by robust science and strong clinical research in partnership with Mayo Clinic, Cologuard is a stool DNA-based colorectal cancer screening test conducted in individuals with average-risk. Cologuard utilizes a biomarker panel that analyzes stool sample of a person for 10 DNA markers, and blood in the stool is analyzed for hemoglobin.

In an effort to battle the gap of colorectal cancer screening, the company has built a one-of-a-kind, user-navigation system which can be used across the nation that offers 24/7 phone as well as online support to deliver help to people with the process of returning and collecting their samples. This method integrates several industry best practices to facilitate a vital tool in the combined efforts to boost colorectal cancer screening.

Exact Sciences is aimed to operate across health care delivery system in order to ensure that those who are seeking an at-home, noninvasive screening test get access to all of the options and is actively collaborating with payer partners to extend coverage in order to include this important screening population.

Source credit: https://www.foxbusiness.com/business-leaders/fda-approves-at-home



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

Nature Tech Corp partners with Aldevron for gene therapy manufacturing
Nature Tech Corp partners with Aldevron for gene therapy manufacturing
By Paroma Bhattacharya

The global cell and gene therapy sector is expected to witness a thriving period of growth over the forthcoming years. In fact, owing to the favorable growth conditions across the industry, numerous biotechnology and p...

Genentech IMbrave150 study meets coprimary endpoints for HCC treatment
Genentech IMbrave150 study meets coprimary endpoints for HCC treatment
By Paroma Bhattacharya

With growing occurrence of liver cancer cases across the globe, the need to find a solution to the ailment is rising steadily among global biotechnology and pharmaceutical firms. Various clinical trials and studies are...

Exicure reveals positive data from XCUR17 clinical trial for Psoriasis
Exicure reveals positive data from XCUR17 clinical trial for Psoriasis
By Paroma Bhattacharya

Clinical trials play a vital role in developing new treatments that could immensely improve a person’s living. Today, researchers and pharmaceutical company are working hard for making breakthroughs in psoriasis ...